Page last updated: 2024-10-18

dihydroxyphenylalanine and Genital Neoplasms, Male

dihydroxyphenylalanine has been researched along with Genital Neoplasms, Male in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Genital Neoplasms, Male: Tumor or cancer of the MALE GENITALIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsukamoto, K1
Furue, M1
Sato, Y1
Takayama, O1
Akasu, R1
Ohtake, N1
Wakamatsu, K1
Ito, S1
Tamaki, K1
Shimada, S1

Other Studies

1 other study available for dihydroxyphenylalanine and Genital Neoplasms, Male

ArticleYear
Generalized melanosis in metastatic malignant melanoma: the possible role of DOPAquinone metabolites.
    Dermatology (Basel, Switzerland), 1998, Volume: 197, Issue:4

    Topics: Aged; Benzoquinones; Dihydroxyphenylalanine; Fatal Outcome; Genital Neoplasms, Male; Humans; Male; M

1998